Cervical cancer is the fourth most common female cancer worldwide and results in over 300
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …

Advanced imaging modalities are increasingly being utilized to tailor treatments.
Neoadjuvant chemotherapy followed by surgery does not improve outcomes in FIGO Stage …

Purpose This guideline reviews the evidence and provides recommendations for the
indications and appropriate techniques of radiation therapy (RT) in the treatment of …

Enhancer of zeste homolog 2 inhibitors (EZH2i) have garnered increased attention owing to
their anticancer activity by targeting EZH2, a well-known cancer-promoting factor. However …

Background Lower limb lymphedema (LLL) is a chronic and incapacitating condition
afflicting patients who undergo lymphadenectomy for gynecologic cancer. This study aimed …

Cervix cancer in many countries is declining and screening programmes and immunisation
will reduce the incidence in the next few decades. This guideline attempts to cover …

Human papillomavirus infection is the precursor for the development of cervical cancer and
is detectable in 99.7% of squamous cell carcinoma and adenocarcinoma cases. Early …

Cervical cancer is the most common cause of female cancer‐related mortality worldwide.
Decreased expression of long noncoding RNA growth arrest‐specific 5 (GAS5) is found in …

Two major treatment modalities in cervical cancer are radiation therapy (RT) and surgery.
Chemotherapy continues to be the main form of systemic therapy adjunctive to definitive …

Defective DNA repair is one of the most important features of tumors. BRCA1/2 participates
in homologous recombination repair as a key tumor suppressor gene. BRCA1/2 mutation is …